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INTRODUCTION
Drug development is the process by which drug companies test incipient molecules and assemble the obligatory evidence required by regulatory agencies to show that a drug is safe and efficacious.The development of incipient drug requires input from many diverse areas, such as biology, biochemistry, pharmacology, animal, toxicology, medical science and biostatics.The criteria for screening these molecules can be the results of in vitro cellular predicated screening assays that are designed to detect the properties that are potential to provide the clinical benefit [1] . The clinical development of incipient drugs traditionally takes place in three phases, the first phase is to identify the maximum tolerable dose, which is the highest dose of the study drug that is deemed tolerable for most subjects, while the second phase is quantifying the drug activity cognate to its potential clinical benefit across a range of factors that may modify the magnitude of the treatment effect, these factors include the dose of the drug or the type of disease. If the activity of the study drug looks promising in phase two, then the drug enters the third phase to develop evidence that the drug is safe enough to administer to the much wider population of patients that will receive it to once marketing approbation is granted [2] .
Most drugs are organic or biologically derived compounds. After the discovery of the cisplatin, there is a growing interest in metal-containing drugs, and medicinal inorganic chemistry covering applications of metals in therapeutics and diagnostics [3] . Some of the metal-based drugs already in market are cisplatin (anticancer drug). Also, cardolite (myocardial imaging agent drug), silverderma
EXPERIMENTAL

Synthesis of Simple and Mixed Metallocephradines and Metallocefepimes
The simple metal-cephradine and cefepime complexes were prepared by mixing molar amount of the metal salts Cr(III), Mn(II), Fe(III), Co(II),Ni(II),Cu(II), Zn(II), Cd(II) and Hg(II) as chloride dissolved in 10 ml water with the calculated amount of the ligand, while the mixed metal cephradine complexes, Fe(III) M(II), where [M(II)=Cu(II) or Co(II)] were prepared by dissolving 1mmol of Fe(III) and 1mmol Cu(II) or Co(II) chloride in 10 ml distilled water, then the resulting solution was added to cephradine (1mmol in 10ml), while the hetero cefepime complexes Fe(III)M(II), where [M(II)=Ni(II) or Cu(II)] were prepared by dissolving 1mmol of Fe(III) and 1mmol Ni(II) chloride or Cu(II) in 10 ml , the resulting solution was then added to cefepime (1mmol in10ml). The mixture was refluxed for about 5 min. The complexes were precipitated and were filtered, then washed several times with a mixture of EtOH-H 2 O and dried in a desiccator over anhydrous CaCl 2 . The metal ion contents were determined by complexmetric titration procedures and atomic absorption spectroscopy. The halogen content was determined by titration with standard Hg (NO 3 ) 2 solution using diphenylcarbazone indicator [24] [25] [26] [27] [28] [29] [30] . The analytical data and physical properties of the studied compounds are represented in Table 1 as previously reported [10] [11] . A representative example for the structure of cephradine and its iron complex was shown in Figure 1 .
Antimicrobial Activity
Antimicrobial activity was determined using the agar well diffusion assay. The tested organisms, S. pyogenes , K. pneumoniae , P. mirabilis, E. fecalis , S. pneumoniae, P. aeruginosa, E. coli and S. aureus were subcultured on nutrient agar medium (Oxoid laboratories, UK) for bacteria and saboroud dextrose agar (Oxoid laboratories, UK) for fungi. Cephradine and cefepimewere used as a positive control for bacterial strains, Amphotericin B was used as a positive control for A. niger, A. flavus, S. racemosum, C. albicans, C. glabrata, F. oxysporum, R. solani and A. solani fungal strains, . The plates were done in triplicate. Bacterial cultures were incubated at 37°C for 24 h, while the other fungal cultures were incubated at 25-30°C from three to seven days. Antimicrobial activity was determined by measurement zone of inhibition [31] .
Determination of MIC
The minimum inhibitory concentration (MIC) of the samples was estimated for each of the tested organisms in triplicates. Varying concentrations of the samples (1000-0.007µg/ml), nutrient broth were added and then a loopful of the test organism previously diluted to 0.5 McFarland turbidity standard was introduced to the tubes. A tube containing broth media only was seeded with the test organisms to serve as control. Tubes containing tested organisms cultures were then incubated at 37°C for 24 h, while the other fungal cultures were incubated at 25-30°C from three to seven days. The tubes were then examined for growth by observing for turbidity [32] .
DNA Cleavage
The DNA cleavage experiment was conducted using charge transfer DNA by gel electrophoresis with the corresponding metal complex in presence of H 2 O 2 as an oxidant [33] [34] . One mg of DNA (0.1µg) was dissolved in 10ml buffer (50mM Tris-HCl-18 mM NaCl buffer pH=7.2), then 20µl was mixed with 2µl of compound and 10µl of H 2 O 2 (4%)and let to stand for 2.30 h in room temperature, after that the samples were electrophoreesed for 1h at 80 V [35] [36] [37] [38] .
Agarose Gel Electrophoresis Protocol
Fifteen microliters of DNA samples mixed with loading buffer were loaded in 1% agarose in 1x TBE buffer containing 5 µl ethidium bromide well and electrophoresed at 100v for 1h. DNA bands were visualized using UV transmitter [35] [36] [37] [38] .
Determination of (Lactase, Sucrase and Maltase) Activity
Ten microliterspencreatine (0.1g/10ml H 2 O containing drops of NaOH) was mixed with5µl of compound and 50µl phosphate buffer (pH=7.4), the mixturewas incubated for 45 min, then 10 µl of substrate lactose or maltose or sucrose (1g %) was added and the mixture was incubated for20 min. The reaction was stopped by thermal denaturation then 100 µl of glucose reagent was added to the previous mixture and incubated for 20 min at room temperature. Absorbance at 450nm was read [39] . Specific activity of (lactase, sucrase and maltase) was reported as U=µg of glucose min -1 mg -1 of protein.
Estimation of α-Amylase Activity
Twentymicrolitersamylase (1g%) was mixed with 5µl of compound and 100 µl phosphate buffer (pH=6.9), then the mixturewas left for 45 min at room temperature. After incubation, 20 µl of substrate soluble starch (1g%) was added and the mixture was incubated for20 min, then 100 µl of glucose reagent was added to the previous mixture and incubated for 20 min. Absorbance was read at 490 nm [40] [41] . Specific activity of amylase is reported as U=µg of maltose min -1 mg -1 of protein 2.4. Determination of Lipase Activity 0.5ml lipase (1g%) enzyme was mixed with 2.5ml olive (100ml olive oil+2 Bitterness bass) and 1.25 ml 0.2M tris buffer (pH=8), then the mixturewas incubated for 2hr at 37°C. At the end of incubation, 1.5ml of ethanol was added. Fatty acids liberated during the reaction were titrated with 0.2M NaOH using ph.ph as an indicator. The color changes from colorless to pink [42] . Specific lipase activity is reported as U=µl of 0.2M NaOH mg -1 of protein.
Determination of Antioxidant Activity
For the determination of scavenging activity of 0.135 mM DPPH free radical in the synthesized compounds, 0.135 mM DPPH in methanol was prepared and 100 µl of this solution was mixed with 100 µl of compounds containing 20-100µg/ml and standard antibiotics. The reaction mixture was left in the dark at room temperature for 30min. the absorbance of the mixture was measured spectrophotometrically at 517nm [43] . The ability of compounds to scavenge DPPH radical was calculated by the equation:
DPPH radical scavenging activity = sample control A A × 100
Preparation of Liver Homogenate
Fresh liver was removed immediately, washed with cold saline solution (0.9% NaCl), weighed, then homogenized in five volume of cold 0.1 M sodium phosphate buffer containing 0.9% NaCl (pH 7.4) using a glass-Teflon homogenizer. All processes were carried out at 4 °C and used as enzyme source for DPPH reductase activity [44] .
The Effect of Synthesized Compounds on DPPH-Reductase Activity
Fiftymicrolitersof liver homogenate was added to10µl of compoundand then the mixturewas incubated for 45 min. After incubation, 50 µl of 300µM DPPH, 50 µl of 100 µM NADPH and 50 µl of 0.1M phosphate buffer (pH=7.6) were added to the previous mixture and leave it in 20 min incubation. Read the absorbance at 520 nm [45] . An extinction coefficient of 4.09 mM -1 cm 1 was used to calculate the number of moles of DPPH reduced per mol of enzyme. 2.8. Anti-Inflammatory Activity 20µl of 10Mm sodium nitroprusside was added to 5 µl phosphate buffer and 5 µl of the complex solution. The mixture was incubated at 25°C for 2.5 hours. After incubation, 20 µl of Griess reagent (1gm of sulphanilic acid+0.1gm naphthylethylene diamine dihydrochloride) was added to the previous mixture and allowed to stand for 30 minutes at room temperature. The absorbance was read at 540 nm [46] . This method is based on the measurement of light absorbance (Ab) at 450nm of erythrocyte hemoglobin whose reaction yield is enhanced/ inhibited through the agency of new material that used as a starter /inhibitor for the peroxide oxidation of lipids in erythrocytic membranes [33] . The blood was collected from healthy human volunteer who had not taken any anti-inflammatory drugs for 2 weeks prior to the experiment and transferred to the centrifuge at 3000 rpm. The packed cells were washed with saline and a 10% suspension in normal saline was made. The reaction mixture 4-5 ml consisted 2 ml of hypotonic saline (0.25% w/v NaCl), 1 ml of 0.15 M phosphate buffer (pH 7.4) and 1 ml of compounds solution (1 mg/ml) in normal saline and 0.5 ml of 10% HRBC in normal saline. For control, 1 ml of isotonic saline was used instead of compounds solution. The mixtures were incubated at 56ºC for 30 min and cooled at running tap water, centrifuge at 3000 rpm for 20 min. The absorbance of supernatant was read at 560 nm using visible spectrophotometer [33] . The experiment was performed in triplicates. The control represents 100% lyses.Stock solution of compounds (1mg/ml) and (serial dilutions: 500, 100, 10, 5 µg/mL) until obtaining the safe dose. The percentage membrane stabilization was calculated using the following formula: 
Antimicrobial Examination
Antibacterial Activity
The in vitro antimicrobial screening of cephradine, cefepime and their complexes were performed against the following bacterial strains, S.pyogenes , K.pneumoniae , P.mirabilis, E.fecalis , S.pneumoniae, P.aeruginosa, E.coli and S.aureusand their efficiency against the bacteria was compared with the standard cephradine and cefepime, Table 2 . The minimum inhibitory concentration (MIC) of some selected complexes, which showed significant activity against selected bacterial species, was determined in comparison to the standard antibiotic cephradine are summarised in Table  3 . The values indicate that the complexes are potentially good inhibitors of the bacterial organisms. It was found that, the chromium complex against K.pneumoniae, P.mirabilis, E.coli and S.aureus was found to be having potentially enhanced antibacterial activities as compared to the standard drug. In a broad-spectrum of the bio-potential property, the iron (2:1), copper (3:1), nickel (1:2), zinc and the mixed metal iron-cobalt (1:1:2) complexes were efficient than cephradine . among these synthesized complexes, it was found that nickel (1:1) and copper (1:2) complexes were more active than cephradine against all tested bacteria except S.pyogenes and E.fecalis. On the other hand, cadmium had similar activty to the standard antibiotic. On the contrary, manganese (1:1), cobalt (1:3) and the mixed metal iron-copper (1:2:2) were not up to the standard against the bacterial strains.
In general, some Metallocephradines were found to be enforced potentially with the cephradine against the same micro-organisms and under the identical experimental conditions. The increase in efficiency of the metal complexes was due to the participation of metal ion on the demolition of bacterial cell process. The process of complexation reduces the polarity of the metal ion, because of partial sharing of its positive charge with the donor group (ligand)and the electrons delocalized within the metal-ligand complex system. Thus, the complexation favours permeation of the metal through the lipid layers of the microbes'cell membrane. Furthermore, the metal complexes form a hydrogen bond with the active centres of organism'scell constituents resulting in the perturbation of the normal cell respiratory process of the microbe. Thus, the complexation enhances the penetration and hence the rate of uptake/entrance of the metal into microbial cell and thus able to kill it [47] .
Also, the higher aggressiveness of zinc (II)complex relative to the rest of the complexes was related to the difference in the effective nuclear charge. During complexation, the decreasing effective nuclear charge (polarity) of the Zn (II) is higher compared to other complexes, which in turn increases the lipophilicity and hence its penetration [48] .
However, nickel (1:2), copper (1:4) and iron-copper (1:1:1) cefepime complexes showed a promising activity higher than the standard antibiotic cefepime. In addition, cobalt (2:1) complex exerted significant activity towords S.pyogenes and K.pneumoniae. It was eight times (MIC=0.49 µg/ml) as active as cefepime (MIC=3.9 µg/ml). In addition, nickel (1:2), copper (4:1) and the mixed metal ironcopper (1:1:1), while, the rest of Metallocefepimes were less active than the reference. The variation in the activity of different complexes against different organisms depends either on the impermeability of the cells of the microbes or on differences in ribosome of microbial cells. The increasing in the activity of the complexes was due to the coordination of metal ion to the antibiotic enhance the lipophilic character of the central metal atom [47] [48] [49] .Generally, metal complexes are more active than the ligands because metal complexes may serve as a vehicle for activation of ligands as the principal cyctotoxic species.
Antifungal Activity
Antifungal activity of cephradine, cefepime and their metal complexes were examined against A.niger, A.flavus, S.racemosum, C.albicans, C.glabrata, F.oxysporum, R.solani and A.solani fungal strains and illustrated in Table 3 . The minimum inhibitory concentration (MIC) of some selected complexes, which showed significant activity against selected fungi species, was determined in comparison to the standard antibiotic cephradine are summarized in Table 4 . The values indicate that the complexes are potentially good inhibitors of the fungi organisms. It was found that chromium (2:1) and nickel (1:1) complexes exerted significant activity towards A.flavus. They were four times (MIC=0.98µg/ml) as active as the standard amphotericin (MIC=3.9µg/ml), while iron (2:1) complex showed activity against A.flavus two times (MIC=1.95 µg/ml) as active as the reference. On the other hand, mercury (1:3) complex exhibited activity against A.niger four times (MIC=0.12µg/ml) as active as amphotericin (MIC=0.49µg/ml) and also exerted activity against A.flavus sixteen times (MIC=0.24µg/ml) as active as amphotericin.It was observed that all Metallocephradines have a promising antifungal activity rather than cephradine. The higher activity of the metal complexes may be due to the chelation reduces the polarity of the metal atom mainly because of partial sharing of its positive charge with donor groups and possible electron delocalization over the entire ring. This consequently increases the lipophilic character of the chelates, favoring their permeation through the lipid layers of the bacterial membrane [50] [51] .
Metallocefepimes are potentially good inhibitors of the fungi organisms. It was found that chromium (2:1) and cobalt (2:1) cefepime complexes exerted significant activity towards A.flavus. They were eight times (MIC=0.49µg/ml) as active as the standard amphotericin (MIC=3.9µg/ml), while coppercefepime complex (1:2) showed activity against A.flavus two times (MIC=1.95 µg/ml) as active as the reference. Also, cadmium cefepime complex (1:1) exhibited activity against A.flavus four times (MIC=0.98µg/ml) as active as amphotericin (MIC=0.49µg/ml).
Most of Metallocefepimes have a promising antifungal activity rather than cefepime, due to the chelation increases the lipophilic character of the chelates, favoring their permeation through the lipid layers of the bacterial membrane [50] [51] . 
Table2. Antibacterial activity of Metallocephradines and Metallocefepimes
Compounds
3.2.DNA-Cleavage
The cleavage efficiency of the complexes compared with that of the control is due to their efficient DNA-binding ability [52] . The cleavage is inhibited bythe free radical scavengers implying that hydroxyl radical or peroxy derivatives mediate the cleavage reaction. The reaction is modulated by a metalloantibiotics bound hydroxyl radical or a peroxo species generated from the co-reactant H 2 O 2 .In the present study, the CT-DNA gel electrophoresis experiment was conducted at 35 °C using our synthesized complexes in the presence of H 2 O 2 as an oxidant. Figure 2 indicates 
Antidiabetic
The effects of Metallocephradines and Metallocefepimes on digestive enzymes were given in Table 6 and Figures (4-5) . It was found that all Metallocephradinesacts as maltase, lactase sucrase, amylase and lipase inhibitors, except Cu-cephradine (1:2) and mixed metal (Fe-Ni)-cephradine complexes did not show inhibitory effect on maltase. These results suggested that the octahedral Cr-cephradinecomplex (2:1) showed the highest inhibitory activity towards maltase activity. Also, Mn (II) and Hg had strong inhibitory effect on maltase, lactase, sucrase, amylase and lipase activity. These results suggested that these Metallocephradines and Metallocefepimes showed its antidiabetic effect via inhibiting maltase, lactase, sucrase, amylase and lipase activity [55] [56] . 
Table6. Effect of Metallocephradines and Metallocefepimeson digestive enzymes
Antioxidant
Assessment of antioxidant activities showed that the activity of the complexes in scavenging of free radical DPPH is fairly good but less than ascorbic acid (113.91%) as positive control in Table 7 , except Fe-cephradine complex in 2:1(M:L), which showed higher activity than ascorbic acid (124.90%), could be due to the coordination of the two Fe(III) ions with cephradine in a stable five membered ring in O h geometry, where the first Fe(III) ion is coordinated to the the carboxylate group and the adjacent nitrogen atom with a stable five membered ring and the second Fe(III) ion is attached to the nitrogen atom of the group -C=N-O and NH 2 with a stable five membered ring. antioxidant than mono-metallic Mn (II), Ni (II) and Hg (II) cephradine complexes in 1:1(M:L) molar ratio could be due to as the number of chelating ring increased, the stability of the formed metal complexes was increased, Cu(II) in 1:2 (M:L) molar ratio showed higher antioxidant activity than Ni (II), Mn (II) and Hg (II) in 1:1 (M:L) molar ratio due to the higher stability of the formed complexes in 1:2 (M:L) molar ratio than metal complexes in 1:1(M:L) molar ratio.
All the metal complexes have exhibited higher scavenging activity than cephradine. The marked antioxidant activity of the metal complexes in comparison to cephradine could be due to the coordination of metal with carboxylate ion vai deprotonation and the adjacent nitrogen atom. Hence, hydrogen of carboxylate ion could be easily donated to the DPPH free radical and convert itself into the stable free radical.
However, DPPH scavenging activity of Metallocefepimes was fairly good but less than cefepime and ascorbic acid aspositive control. Significant activity was found in both Zn ( 
DPPH Reductase Activity
The results of spectrophotometric investigation of redox interactionof oxidized form of Cytochrome c with cephradine, cefepime and their metal complexes are given in Table 7 . It was found that cephradine and its metal complexes have a moderate DPPH-reductase activity, which is less than ascorbic acid as a positive control. Fe (III), Co (II), [Fe (III)-Co (II)] and [Fe (III)-Ni (II)] cephradine complexes showed the highest rate of cytochrome c reduction and also antioxidant activity in comparison with the parent antibiotic but less than the ascorbic acid, this may be attributed to the highest stability of these metal complexes.
It was found that Metallocefepimes gave DPPH reductase activity but less than ascorbic acid as a positive control. Among the examined metal complexes, it was observed that Cu-cefepime complex in 1:3 (M:L) molar ratio exhibited higher DPPH reductase activity than cefepime, this may be due to the coordination of Cu (II) to the carboxylate group and the adjacent nitrogen atom with a stable five membered ring in octahedral geometry. 
Table7. The effect of Metallocephradines and Metallocefepimes on antioxidant and DPPH reductase activity
